We are global leader in the laboratory diagnostics market, specializing in the immunodiagnostics and molecular diagnostics segments. For over 50 years our Group has been developing, producing and commercializing diagnostic tests: we support clinical laboratory needs and activities, providing solutions that are reliable, innovative, fully automated and standardized. We continually invest in Research & Development, using our own distinctive expertise in the field to deliver a high level of innovation.
Diasorin, The Diagnostic Specialist
All our technology in a new dimension. LIAISON® XS delivers a high technology solution for immunochemistry tests that allows laboratories to improve efficiency and clinical effectiveness for routine and specialty testing.Discover All Systems
LIAISON® XL is the fully automated chemiluminescence analyzer, performing complete sample processing (sample pre-dilutions, sample and reagent dispensing, incubations, wash processes, etc.) as well as measurement and evaluation. The innovative features of the system allow LIAISON® XL to improve efficiency in the immunoassay laboratories: fully automated solution, quality of results, flexible configuration, high efficiency.Discover All Systems
DiaSorin launches FDA-Cleared LIAISON® Calprotectin test in the US market
DiaSorin launches the new LIAISON® QUANTIFERON®-TB GOLD PLUS ASSAY as an aid for latent tuberculosis
DiaSorin launches Hepatitis Delta (Hdv) test on LIAISON® XL platform
DiaSorin launches the new LIAISON® SHBG test for the diagnosis of androgen-related disorders